Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fesoterodine in elderly patients with overactive bladder
NCT00798434Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jun 2008
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 4 trial of fesoterodine in overactive bladder (OAB), sponsored by Pfizer. Started Jun 2008; status: completed.
02
Drugs
fesoterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00798434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00798434.